tiprankstipranks

China NT Pharma Group Schedules Board Meeting for Financial Results Approval

Story Highlights
China NT Pharma Group Schedules Board Meeting for Financial Results Approval

China NT Pharma Group Co., Ltd. ( (HK:1011) ) has provided an announcement.

China NT Pharma Group Co., Ltd. has announced that its board of directors will convene on March 31, 2025, to approve the release of the company’s final results for the year ending December 31, 2024. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder interests.

More about China NT Pharma Group Co., Ltd.

China NT Pharma Group Co., Ltd. operates within the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company primarily serves markets in China and is engaged in providing a range of healthcare solutions.

YTD Price Performance: -12.96%

Average Trading Volume: 139,047

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: HK$158.4M

For a thorough assessment of 1011 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App